Mass Vaccination in a Pandemic - Benefits versus Risks: Interview with Geert Vanden Bossche

First published at 22:17 UTC on April 13th, 2021.

FAlzinar

FAlzinar

subscribers

Dr. Geert Vanden Bossche, PhD. He is a vaccine research expert. He has a long list of companies and organizations he’s worked with on vaccine discovery and preclinical research, including GSK, Novartis, Solvay Biologicals, and Bill & Melinda Gat…

MORE
CategoryEducation
SensitivityNormal - Content that is suitable for ages 16 and over